How Staate decides what to say about a peptide or supplement, where the facts come from, and what happens when a page gets something wrong.
Every claim about what a compound does carries one of three labels, so you can see how strong the evidence is without opening the study.
A claim with no source behind it does not go on the page.
Each peptide page also gives one overall grade, based on the best human evidence that exists for it:
The grade describes how much has been tested, not whether something will work for you. How to read peptide research explains the study types behind it.
Pages link to the primary source whenever one exists: the paper on PubMed or the journal site, the trial record on ClinicalTrials.gov, the FDA label or Federal Register notice, the WADA Prohibited List. The link goes to the specific paper, not to a search page. Reviews and news coverage are used for context and labeled as reviews.
Vendor product pages, unsourced blog posts and AI-generated summaries are not cited as evidence. Numbers on a page (trial sizes, percentages, half-lives) come from the linked source. If the source does not give a number, the page does not either.
Regulatory status changes often, especially for compounded and research peptides. Legal status is checked against the FDA, the Federal Register and WADA. When a status changes, the page is updated and its last-updated date moves with it.
Public peptide pages do not give dosing instructions. Studied-dose tables, where they exist, are in the free members area and show what a trial used, not a recommendation. Nothing on Staate is medical advice. Talk to a licensed clinician before starting, stopping or combining anything.
If you find an error, a broken source or a newer study a page is missing, email [email protected] with the page and the source. It gets checked against the primary source, the page is fixed if it was wrong, and its last-updated date changes. When a correction changes what a page concludes, the page says so.
Pages are written and edited by Mark, Staate's founder and editor.